NEW! The Fullintel Hub AI Edition is now live - Learn More Today!

Blog

What Makes GPT 4 Stand Out from GPT 3.5: The Most Notable Differences

You may have heard the latest buzz in the AI world: It's all about GPT-4, the new and improved version of ChatGPT. It's like the next level of AI and it’s got a ton of cool new features.  But here's the catch: You can only get your hands on it with a ChatGPT Plus...

Fullintel’s Angela Dwyer Recognized as one of this year’s Data and Media Measurement Game-Changer by PRNEWS

Fullintel’s Head of Insights, Angela Dwyer, has been recently named a data and measurement game-changer in the class of 2023 PRNEWS People of the Year. The award is the latest in a string of high-profile recognitions for Dwyer. Earlier this year she received a PRNEWS...

Threads: 7 Reasons Why The Hype Cycle is Wrong

Threads is the newest social media platform brought to the world by Meta. It was released earlier in July, and if you believe a heavily reported SimilarWeb report (or this Medium post) you might think Threads is already “dead on arrival” after just a few weeks.  But...

Barbie The Movie – Media Analysis: Did the Barbie Movie Successfully Change Perceptions?

Barbie–the name itself stirs mixed emotions–some feel pleasant nostalgia of their own Barbie, convertible and dreamhouse, others feel resentment for an unattainable standard of beauty or even a sexist image. The Barbie Movie generated significant media coverage–over...

Top Pharma News in July 2023

AI Takes Center Stage with Media Buzz Around its Real-World Impact AI is reshaping the pharmaceutical landscape by significantly reducing the time and costs involved in developing new drugs and bringing about efficiencies. It plays a vital role in various stages of...

Three Factors to Help Pharma Companies Build Brand Trust Through the Media: A Fullintel Study

Trust in pharmaceutical companies has increased since the pandemic, but as the least trusted subsector of healthcare, the industry still has a steep road to climb. However, by integrating messaging and content reaffirming key attributes of trustworthiness – including...

Expect Deep Dives into Patient Advocacy and other Hot Topics at Pharma PR & Communications Summit East

The Pharma PR & Communications Summit West in San Diego is now in the books, which means one thing: It’s almost time for the Pharma PR & Communications Summit East in Jersey City, New Jersey.  Unlike the west-coast event, which is still in its relative...

7 Major Differences Between Twitter and Threads, and they’re great!

I remember sending Tweets by text message. Later, when I finally could Tweet in an interface Obama was on the cusp of his first election win. I'll give anything a try; meanwhile, trying to nicotine patch my way off Twitter, I downloaded Threads, Instagram's...

ESG Isn’t a Four Letter Word

Divisive politics, according to the CEO of investment firm Blackrock, has made the term “ESG” (short for environmental, social, and governance) too hot to handle. Larry Fink said he was ashamed that discussions related to ESG have become politicized, as reported by...

Top Pharma News in June 2023

FDA Greenlights Neuralink’s Human Trials for Revolutionary Brain-Computer Interface, Captivating Audiences Worldwide The pharmaceutical industry is experiencing remarkable growth and positive prospects in 2023, driven by technological advancements, increased research...

Sign up for email updates

Get PR, media monitoring, and media intelligence tips straight to your inbox and become a better communicator.

    Tweets

    See it live

    Schedule a time with one of our product specialists to see a live, one-on-one demo.